Professor Redouane Samlali is a renowned radiation oncologist, healthcare entrepreneur, and President & Co-Founder of Oncorad Group, one of Morocco’s leading private healthcare networks. With more than four decades of experience in oncology, he has been instrumental in transforming cancer care through advanced technologies, multidisciplinary treatment models, and patient-centered innovation. Under his leadership, Oncorad Group has grown into a leading healthcare organization recognized for pioneering innovations in oncology, robotic surgery, precision radiotherapy, and AI-enabled medical technologies. His vision has helped expand access to specialized, high-quality healthcare while positioning Morocco as a regional hub for medical excellence and innovation. At AIMedEx 2026, Professor Redouane Samlali will share insights on the future of oncology and digital healthcare, exploring how artificial intelligence, precision medicine, and advanced medical technologies are transforming cancer diagnosis, treatment, and patient care across the globe.